东诚药业 (002675.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(东诚药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 741,720,549.75773,482,317.71647,229,057.46690,304,287.73800,333,136.57934,509,977.98850,500,484.35
 营业收入(元) 741,720,549.75773,482,317.71647,229,057.46690,304,287.73800,333,136.57934,509,977.98850,500,484.35
二、营业总成本(元) 680,562,127.52666,864,933.62597,994,534.45631,132,970.38679,317,202.29751,248,872.65764,778,405.24
 营业成本(元) 391,077,880.41422,688,683.29363,780,583.66353,255,462.63463,750,806.33541,945,464.79447,006,265.63
 研发费用(元) 62,964,878.0345,713,758.3345,209,265.3072,460,730.2940,829,872.0836,610,891.9247,321,769.47
 营业税金及附加(元) 7,566,198.749,061,113.847,201,400.259,135,489.478,287,571.548,695,009.347,751,517.91
 销售费用(元) 111,939,465.1498,194,132.63103,237,681.29101,408,957.24103,393,436.66137,689,377.90165,018,368.72
 管理费用(元) 58,434,079.0174,676,451.2674,807,110.6864,804,885.7552,967,193.5855,278,830.3977,572,608.92
 财务费用(元) 48,579,626.1916,530,794.273,758,493.2730,067,445.0010,088,322.10-28,970,701.6920,107,874.59
  其中:利息费用(元) 45,918,593.647,085,698.9014,843,120.5924,938,472.4110,663,469.4310,196,535.1010,961,264.49
  其中:利息收入(元) -1,767,086.664,045,807.911,469,893.644,005,171.082,722,833.122,645,779.863,406,131.54
 资产减值损失(元) -1,447,437.71-29,360,857.2932,985,557.60-112,071,621.96---
 信用减值损失(元) 337,605.77-7,251,303.69-5,399,108.541,487,045.382,202,694.824,386,328.27-1,562,467.80
三、其他经营收益
 加:公允价值变动收益(元) 338,840.33------
 加:投资收益(元) -5,263,507.30-5,051,626.903,053,594.10-9,397,710.847,659,949.43139,133.43-7,055,328.88
  其中:对联营企业和合营企业的投资收益(元) -6,774,449.23---16,798,670.89-13,626,968.97--
 资产处置收益(元) 16,799.89-12,060.5677,337.4624,467.91-1,640.2634,139.883,261.96
 其他收益(元) 2,854,536.088,632,427.124,057,360.998,459,169.864,369,612.583,513,610.689,589,346.86
四、营业利润(元) 57,995,259.2973,814,716.1984,009,264.62-71,801,194.78135,432,447.81191,334,317.5986,696,891.25
 加:营业外收入(元) 19,465.993,742.55102,516.3159,313.5449,675.70212,012.169,471.27
 减:营业外支出(元) 1,019,523.77381,362.80122,406.293,879,832.17411,186.22304,249.49116,004.92
五、利润总额(元) 56,995,201.5173,437,095.9483,989,374.64-75,621,713.41135,070,937.29191,242,080.2686,590,357.60
 减:所得税费用(元) 25,266,859.8619,440,026.8918,058,435.0310,858,497.4617,440,491.1731,090,867.4523,675,382.51
六、净利润(元) 31,728,341.6553,997,069.0565,930,939.61-86,480,210.87117,630,446.12160,151,212.8162,914,975.09
(一)按经营持续性分类
  持续经营净利润(元) 31,728,341.6553,997,069.0565,930,939.61-86,480,210.87117,630,446.12160,151,212.8162,914,975.09
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 55,078,313.3547,462,281.2564,327,510.75-76,075,763.33101,505,127.46134,199,772.1250,106,641.46
  少数股东损益(元) -23,349,971.706,534,787.801,603,428.86-10,404,447.5416,125,318.6625,951,440.6912,808,333.63
 扣除非经常性损益后的净利润(元) 44,569,737.3350,896,723.5154,849,972.63-38,216,019.2477,268,744.13131,037,054.2642,389,249.65
七、每股收益
 一、基本每股收益(元) 0.070.060.08-0.090.120.160.06
 二、稀释每股收益(元) 0.070.060.08-0.090.120.160.06
八、其他综合收益(元) 16,216,995.87-8,016,059.28-1,887,785.685,306,206.7927,699.66598,233.42-2,513,718.76
 归属于母公司股东的其他综合收益(元) 10,669,162.82-6,067,144.39-737,757.852,748,887.701,772,926.94-47,527.59-2,463,157.20
 归属于少数股东的其他综合收益(元) 5,547,833.05-1,948,914.89-1,150,027.832,557,319.09-1,745,227.28645,761.01-50,561.56
九、综合收益总额(元) 47,945,337.5245,981,009.7764,043,153.93-81,174,004.08117,658,145.78160,749,446.2360,401,256.33
 归属于母公司所有者的综合收益总额(元) 65,747,476.1741,395,136.8663,589,752.90-73,326,875.63103,278,054.40134,152,244.5347,643,484.26
 归属于少数股东的综合收益总额(元) -17,802,138.654,585,872.91453,401.03-7,847,128.4514,380,091.3826,597,201.7012,757,772.07
公告日期 2024-10-292024-08-312024-04-272024-04-272023-10-272023-08-242023-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院